73 research outputs found
PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR-IX-DEFICIENT PATIENT WITH AN INHIBITOR
Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79
Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B
A Five Year Experience of the Use of Factor IX Type DE(I) Concentrate for the Treatment of Christmas Disease at Oxford
- …